"For many people with type 2 diabetes, it is a struggle to achieve both A1C control and weight loss, since obesity has historically been harder to treat for those with type 2 diabetes," said TRANSCEND-T2D-1 Efficacy Results Retatrutide also showed clinically meaningful improvements from baseline across key cardiovascular risk factors, including non-HDL cholesterol, triglycerides and systolic blood pressure
Diet and exercise will always be essential to any plan to lose weight or keep it off
Diabetes 63:24862497 Nauck MA, Petrie JR, Sesti G et al (2016) A phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes
We can provide you a Certificate of Analysis (COA) and relevant test spectra or samples to verify product quality